uniQure - M&A Summary and Business Overview

Life ScienceCompany

uniQure M&A Summary

uniQure has acquired 3 companies, including 1 in the last 5 years.

uniQure’s largest acquisition to date was in 2021, when it acquired Corlieve Therapeutics SAS for $52M. uniQure has acquired in 3 countries. The Company’s most targeted sectors include life science (100%).

uniQure Business Overview

Where is uniQure headquartered?

uniQure is headquartered in Amsterdam, Netherlands.

What is uniQure’s revenue?

uniQure disclosed revenue of 16M USD for 2023 and 106M USD for 2022.

How many employees does uniQure have?

uniQure has 480 employees.

What sector is uniQure in?

uniQure is a life science company.

When was uniQure founded?

uniQure was founded in 1998.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Advisors 1

uniQure

uniQure N.V.

Paasheuvelweg 25a,
Amsterdam, 1105 BP
Netherlands,
+31 20 240 6000
www.uniqure.com

uniQure is a gene therapy company that developed the first and only gene therapy product to receive regulatory approval in the European Union. Gene therapy is a technique for correcting defective or missing genes that cause diseases. uniQure is primarily focused on rare genetic diseases, and will also start developing gene therapies for chronic and degenerative diseases that affect larger populations. uniQure was founded in 1998 and is based in Amsterdam, the Netherlands.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 2 - 1 - - - 3
vol $3M $52M $56M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Corlieve Therapeutics SAS 2021-06-22 52M EUR Add-on Acquisition
Paris, France · www.corlieve.com
InoCard GmbH 2014-08-11 3M EUR Add-on Acquisition
Heidelberg, Germany
Amsterdam Molecular Therapeutics (AMT) Holding N.V. 2012-02-17 - Add-on Acquisition
Amsterdam, Netherlands · www.amtbiopharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 56M (100%) - -
Total 3 $56M - -

By Geo

State/Country Buy Value Sell Value
France 1 52M - -
Germany 1 3M - -
Netherlands 1 - - -
Domestic 1 (33%) - - -
Cross-border 2 (67%) 56M (100%) - -
Total 3 $56M - -

Top M&A Advisors

Legal Deals
Morgan Lewis
1

Deal Values

buy # Total
< $100M 2 $56M
TOTAL $56M
Largest Corlieve Therapeutics SAS
$52M (2021-06-22)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.